Drug Type Fusion protein |
Synonyms PD-L1/CD70 fusion protein - KAHR Medical + [1] |
Target |
Mechanism CD27 stimulants(CD27 antigen stimulants), PDL1 inhibitors(Programmed death-ligand 1 inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | IL | - |